Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Livia Ruffini

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Clinical Lung Cancer|August 28, 2024
Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLCAlessandro Leonetti, Veronica Cervati, Roberta Minari, et al.
Leukemia & Lymphoma|June 14, 2011
Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern ItalyStefano Luminari, Marina Cesaretti, Chiara Tomasello, et al.
Frontiers in Oncology|October 29, 2021
[<sup>18</sup>F](2<i>S</i>,4<i>R</i>)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in MyelomaSilvia Valtorta, Denise Toscani, Martina Chiu, et al.
Journal of Clinical Medicine|December 30, 2025
The Vagal Link: Autonomic Nervous System Dysfunction in Cardiac AmyloidosisFederico Barocelli, Eleonora Canu, Nicolò Pasini, et al.
Acta Diabetologica|May 2, 2025
Hyperglycemia in the diabetic range, but not previous diagnosis of diabetes mellitus, is an independent indicator of poor outcome in patients hospitalized for severe COVID-19Alessandra Dei Cas, Raffaella Aldigeri, Elisa Eletto, et al.
European Radiology|July 15, 2009
"In-house" pharmacological management for computed tomography coronary angiography: heart rate reduction, timing and safety of different drugs used during patient preparationErica Maffei, Alessandro A Palumbo, Chiara Martini, et al.
European Radiology|February 19, 2009
Prognostic value of computed tomography coronary angiography in patients with suspected coronary artery disease: a 24-month follow-up studyAnnachiara Aldrovandi, Erica Maffei, Alessandro Palumbo, et al.
Cancer Chemotherapy and Pharmacology|November 22, 2013
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinibMarcello Tiseo, Massimo Ippolito, Maura Scarlattei, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 13, 2021
Lung uptake detected by <sup>68</sup>Ga-PSMA-11 PET/CT in prostate cancer patients with SARS-CoV-2: a case seriesAndrea Farolfi, Silvi Telo, Paolo Castellucci, et al.
La Radiologia Medica|October 13, 2025
Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial-NCT 05022914)Giulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Clinical Lung Cancer|August 28, 2024
Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLCAlessandro Leonetti, Veronica Cervati, Roberta Minari, et al.
Leukemia & Lymphoma|June 14, 2011
Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern ItalyStefano Luminari, Marina Cesaretti, Chiara Tomasello, et al.
Frontiers in Oncology|October 29, 2021
[<sup>18</sup>F](2<i>S</i>,4<i>R</i>)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in MyelomaSilvia Valtorta, Denise Toscani, Martina Chiu, et al.
Journal of Clinical Medicine|December 30, 2025
The Vagal Link: Autonomic Nervous System Dysfunction in Cardiac AmyloidosisFederico Barocelli, Eleonora Canu, Nicolò Pasini, et al.
Acta Diabetologica|May 2, 2025
Hyperglycemia in the diabetic range, but not previous diagnosis of diabetes mellitus, is an independent indicator of poor outcome in patients hospitalized for severe COVID-19Alessandra Dei Cas, Raffaella Aldigeri, Elisa Eletto, et al.
European Radiology|July 15, 2009
"In-house" pharmacological management for computed tomography coronary angiography: heart rate reduction, timing and safety of different drugs used during patient preparationErica Maffei, Alessandro A Palumbo, Chiara Martini, et al.
European Radiology|February 19, 2009
Prognostic value of computed tomography coronary angiography in patients with suspected coronary artery disease: a 24-month follow-up studyAnnachiara Aldrovandi, Erica Maffei, Alessandro Palumbo, et al.
Cancer Chemotherapy and Pharmacology|November 22, 2013
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinibMarcello Tiseo, Massimo Ippolito, Maura Scarlattei, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 13, 2021
Lung uptake detected by <sup>68</sup>Ga-PSMA-11 PET/CT in prostate cancer patients with SARS-CoV-2: a case seriesAndrea Farolfi, Silvi Telo, Paolo Castellucci, et al.
La Radiologia Medica|October 13, 2025
Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial-NCT 05022914)Giulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, et al.
Pageof 8